Associated Papers
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.
Richman J et al.
Breast Cancer Research and Treatment, 2024
38709373 (PubMed )
Supplement: 10549_2024_7311_MOESM2_ESM.xlsx › Suppl_Table_5
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Zivanovic Bujak A et al.
Plos Medicine, 2020
33001984 (PubMed )
Supplement: pmed.1003363.s013.xlsx › S4_Table
The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription.
Malik N et al.
Nature Communications, 2019
31061501 (PubMed )
Supplement: 41467_2019_10102_MOESM1_ESM.pdf
The RUNX Transcriptional Coregulator, CBFβ, Suppresses Migration of ER+ Breast Cancer Cells by Repressing ERα-Mediated Expression of the Migratory Factor TFF1.
Pegg HJ et al.
Molecular Cancer Research : Mcr, 2019
Whole-genome analysis informs breast cancer response to aromatase inhibition.
Ellis MJ et al.
Nature, 2012
Select a paper to view details